Multiple myeloma Leu167Ile (c.499C>A) mutation prevents XBP1 mRNA splicing

British Journal of Haematology

Volumn 161, Issue 6, 2013, Pages 898-901

  Hong, Shin Yee ^a   Hagen, Thilo ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Bortezomib; Multiple myeloma; Mutation; Splicing; XBP1

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; MESSENGER RNA; THAPSIGARGIN; X BOX BINDING PROTEIN 1;

ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE LOCATION; GENE MUTATION; HUMAN; LETTER; MULTIPLE MYELOMA; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RNA SPLICING; SEQUENCE ALIGNMENT; XBP1 GENE;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; DNA-BINDING PROTEINS; HUMANS; MULTIPLE MYELOMA; MUTATION; NUCLEIC ACID CONFORMATION; RNA SPLICING; TRANSCRIPTION FACTORS;

EID: 84878492028     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12310     Document Type: Letter

References (10)

1. Bagratuni, T., Wu, P., Gonzalez de Castro, D., Davenport, E.L., Dickens, N.J., Walker, B.A., Boyd, K., Johnson, D.C., Gregory, W., Morgan, G.J. & Davies, F.E. (2010) XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments. Blood, 116, 250-253.
2. Carrasco, D.R., Sukhdeo, K., Protopopova, M., Sinha, R., Enos, M., Carrasco, D.E., Zheng, M., Mani, M., Henderson, J., Pinkus, G.S., Munshi, N., Horner, J., Ivanova, E.V., Protopopov, A., Anderson, K.C., Tonon, G. & DePinho, R.A. (2007) The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell, 11, 349-360.
3. Chapman, M.A., Lawrence, M.S., Keats, J.J., Cibulskis, K., Sougnez, C., Schinzel, A.C., Harview, C.L., Brunet, J.P., Ahmann, G.J., Adli, M., Anderson, K.C., Ardlie, K.G., Auclair, D., Baker, A., Bergsagel, P.L., Bernstein, B.E., Drier, Y., Fonseca, R., Gabriel, S.B., Hofmeister, C.C., Jagannath, S., Jakubowiak, A.J., Krishnan, A., Levy, J., Liefeld, T., Lonial, S., Mahan, S., Mfuko, B., Monti, S., Perkins, L.M., Onofrio, R., Pugh, T.J., Rajkumar, S.V., Ramos, A.H., Siegel, D.S., Sivachenko, A., Stewart, A.K., Trudel, S., Vij, R., Voet, D., Winckler, W., Zimmerman, T., Carpten, J., Trent, J., Hahn, W.C., Garraway, L.A., Meyerson, M., Lander, E.S., Getz, G. & Golub, T.R. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature, 471, 467-472.
4. Cox, J.S. & Walter, P. (1996) A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response. Cell, 87, 391-404.
5. Gu, J.L., Li, J., Zhou, Z.H., Liu, J.R., Huang, B.H., Zheng, D. & Su, C. (2012) Differentiation induction enhances bortezomib efficacy and overcomes drug resistance in multiple myeloma. Biochemical and biophysical research communications, 420, 644-650.
6. Hooks, K.B. & Griffiths-Jones, S. (2011) Conserved RNA structures in the non-canonical Hac1/Xbp1 intron. RNA Biology, 8, 552-556.
7. Kim, R., Emi, M., Tanabe, K. & Murakami, S. (2006) Role of the unfolded protein response in cell death. Apoptosis, 11, 5-13.
8. Ling, S.C., Lau, E.K., Al-Shabeeb, A., Nikolic, A., Catalano, A., Iland, H., Horvath, N., Ho, P.J., Harrison, S., Fleming, S., Joshua, D.E. & Allen, J.D. (2012) Response of myeloma to the proteasome inhibitor bortezomib is correlated with the unfolded protein response regulator XBP-1. Haematologica, 97, 64-72.
9. Moreno, A.A., Mukhtar, M.S., Blanco, F., Boatwright, J.L., Moreno, I., Jordan, M.R., Chen, Y., Brandizzi, F., Dong, X., Orellana, A. & Pajerowska-Mukhtar, K.M. (2012) IRE1/bZIP60-mediated unfolded protein response plays distinct roles in plant immunity and abiotic stress responses. PLoS ONE, 7, e31944.
10. Tirosh, B., Iwakoshi, N.N., Glimcher, L.H. & Ploegh, H.L. (2006) Rapid turnover of unspliced Xbp-1 as a factor that modulates the unfolded protein response. Journal of Biological Chemistry, 281, 5852-5860.